drugset / Trial / NCT00181649
Recombinant Human Prolactin for Lactation Induction
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the safety and determine the effects of the hormone prolactin on lactation (breast milk production).
Timeline
- Start
- 2006-09
- Primary completion
- 2011-05
- Completion
- 2011-05
Outcome
Outcome not reported
Stopped (Enrollment): “Not able to recruit any subjects.”
Publications
- Results Powe CE, Puopolo KM, Newburg DS, Lonnerdal B, Chen C, Allen M, Merewood A, Worden S, Welt CK. Effects of recombinant human prolactin on breast milk composition. Pediatrics. 2011 Feb;127(2):e359-66. doi: 10.1542/peds.2010-1627. Epub 2011 Jan 24.
- Results Powe CE, Allen M, Puopolo KM, Merewood A, Worden S, Johnson LC, Fleischman A, Welt CK. Recombinant human prolactin for the treatment of lactation insufficiency. Clin Endocrinol (Oxf). 2010 Nov;73(5):645-53. doi: 10.1111/j.1365-2265.2010.03850.x.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Prolactin | Protein / enzyme biologic | 60 ug/kg | Subcutaneous |